PubRank

Robert B M Landewé

Author PubWeight™ 40.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004 2.99
2 The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in response to the US Food and Drug Administration's comments and concerns. Arthritis Rheumatol 2014 2.14
3 What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004 2.13
4 EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 2013 2.05
5 The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing. Arthritis Rheum 2003 1.84
6 Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol 2005 1.70
7 Non-steroidal anti-inflammatory drugs for acute gout. Cochrane Database Syst Rev 2014 1.60
8 Smoking and overweight determine the likelihood of developing rheumatoid arthritis. Ann Rheum Dis 2012 1.30
9 International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol 2007 1.11
10 Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. Ann Rheum Dis 2010 1.10
11 International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures. J Rheumatol 2007 1.04
12 MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor. Ann Rheum Dis 2012 1.00
13 EULAR definition of erosive disease in light of the 2010 ACR/EULAR rheumatoid arthritis classification criteria. Ann Rheum Dis 2013 0.97
14 Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160. Ann Rheum Dis 2012 0.97
15 How well are the ASAS/OMERACT Core Outcome Sets for Ankylosing Spondylitis implemented in randomized clinical trials? A systematic literature review. Clin Rheumatol 2014 0.95
16 Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015 0.94
17 Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary? J Rheumatol 2005 0.92
18 Assessment of global disease activity in RA patients monitored in the METEOR database: the patient's versus the rheumatologist's opinion. Clin Rheumatol 2013 0.89
19 Association of joint space narrowing with impairment of physical function and work ability in patients with early rheumatoid arthritis: protection beyond disease control by adalimumab plus methotrexate. Ann Rheum Dis 2012 0.89
20 Endorsement of definitions of disease activity states and improvement scores for the Ankylosing Spondylitis Disease Activity Score: results from OMERACT 10. J Rheumatol 2011 0.88
21 Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis 2012 0.87
22 Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane Database Syst Rev 2012 0.85
23 Methotrexate treatment and mortality in rheumatoid arthritis. Lancet 2002 0.84
24 Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7. J Rheumatol 2005 0.83
25 Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'? Nat Clin Pract Rheumatol 2005 0.80
26 Comorbidities in patients with spondyloarthritis. Rheum Dis Clin North Am 2012 0.80
27 Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol 2013 0.80
28 OMERACT magnetic resonance imaging initiative on structural and inflammatory lesions in ankylosing spondylitis--report of a special interest group at OMERACT 10 on sacroiliac joint and spine lesions. J Rheumatol 2011 0.80
29 Diagnostic and predictive value of acute-phase reactants in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl 2011 0.80
30 Methotrexate saves lives: a pearl of observational research. Arthritis Rheum 2013 0.79
31 Magnetic resonance imaging in the diagnosis of ankylosing spondylitis: be aware of gold standards and circularity. J Rheumatol 2010 0.79
32 Updating the OMERACT filter: core areas as a basis for defining core outcome sets. J Rheumatol 2014 0.79
33 Diagnostic and prognostic value of synovial biopsy in adult undifferentiated peripheral inflammatory arthritis: a systematic review. J Rheumatol Suppl 2011 0.78
34 Justification for including MRI as a tool in the diagnosis of axial SpA. Nat Rev Rheumatol 2010 0.78
35 Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis. Rheumatology (Oxford) 2010 0.77
36 Brief report: erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective followup of patients with ankylosing spondylitis. Arthritis Rheumatol 2014 0.77
37 Dramatic repair of joint damage in psoriatic arthritis. J Rheumatol 2011 0.75
38 Tools for monitoring spondyloarthritis in clinical practice. Nat Rev Rheumatol 2009 0.75
39 [The multidisciplinary practice guideline "The responsible use of biologicals"]. Ned Tijdschr Geneeskd 2011 0.75
40 Concomitant therapies as an outcome measure. Part 1: Drugs. J Rheumatol 2005 0.75
41 Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study. Clin Rheumatol 2014 0.75
42 Cardiovascular Morbidity and Mortality Among Working Individuals With Rheumatic Disease: Results From a Large Prospective Cohort Study. J Clin Rheumatol 2015 0.75
43 Effects of cardiovascular comorbidities on work participation in rheumatic diseases: a prospective cohort study among working individuals. Arthritis Care Res (Hoboken) 2014 0.75
44 Algorithm for identification of undifferentiated peripheral inflammatory arthritis: a multinational collaboration through the 3e initiative. J Rheumatol Suppl 2011 0.75